For Research Use Only. Not for Human Consumption.
Recorded market$116.26Recorded exact-size market estimate: 116.26 USD for one 24 IU container (4.844179 USD/IU). Arithmetic mean of 10 recorded supplier prices for this same vial or container size and formulation, with no extrapolation from other sizes. Supplier observation dates: Oct 11, 2026 UTC. Non-USD prices use ECB exchange rates dated October 9, 2026. Shipping excluded; supplier tax treatment is retained as recorded. This is a dated price comparison, not a former Peptide Serum price or an assurance of potency, purity, dosing or medical equivalence.Public price$116.00Member price$55.3352.4% lessMembers save $60.93 on this item vs. recorded market
Recombinant somatropin, 24 IU in one vial, for laboratory research.
Both catalog entries are labeled as one vial. Compare 10 IU and 24 IU directly; IU and mg are different units.
Exact-size price research
Supplier observation dates: Oct 11, 2026 UTC. This reference uses recorded prices for the same 24 IU vial or container and formulation. No prices are extrapolated from smaller or larger vials. Peptide Serum member unit prices refresh from the current catalog. Paid PRO membership is required for member pricing.
$2.31/IU52.4% less
Peptide Serum reference: Member unit price (USD), available with verified paid PRO membership; excludes shipping and applicable taxes. Read from catalog: Oct 23, 2026 05:16 UTC. 1 x 24 IU = 24 IU total.
Source: PeptideSerum-exact-size-market-comparison.xlsx. One selected single-container price per supplier domain, for the same labeled vial size and formulation. Blends match recorded component amounts. The arithmetic mean uses the first ten selected supplier prices in recorded Google discovery order, or the true smaller sample when ten could not be found. No size scaling, mg-to-IU conversion, pack discount or minimum price range is substituted.
The green percentage, when shown, compares the member price for every visitor: (recorded exact-size market average minus Peptide Serum member price) divided by the recorded market average. Unrounded values are used and the percentage is rounded down to one decimal. It is omitted when the member price is equal to or above the reference or the refreshed snapshot cannot be confirmed. Member pricing requires verified paid PRO membership.
These are dated price observations, not live available supplier offers. Shipping is excluded. Supplier tax treatment is retained as recorded and can differ. Memberships, clinical qualifications, ancillary supplies and availability can affect comparability; source notes retain these limitations. Some observations were sold out. Seller domains may be correlated through one manufacturer. This is not a revenue-ranked or complete-market survey.
Non-USD native prices are converted using ECB reference rates dated October 9, 2026. Recorded exchange-rate source. Original prices and currencies are shown below. Currency conversion does not make tax treatment or purchasing conditions identical.
| Source / recorded date | Exact vial / native price | USD per IU | Recorded coverage / conditions |
|---|---|---|---|
| Peptiqo Oct 11, 2026 UTC | One 24 IU container; 60.00 USD | $2.50/IU | lyophilized powder; 500 in stock Specifications state sealed laboratory research vial, 24 IU per vial, lyophilized powder. Current public USD 60 sale; list USD 70. Price observation; no COA authentication is implied by inclusion. |
| Copenhagen Chems Oct 11, 2026 UTC | One 24 IU container; 227.99 EUR | $10.65/IU | lyophilized powder; publicly listed Exact24IUselected, quantitypervial24IU, lyophilizedpowder, EUR227.99publicprice. Photoone24IUvial,no kit/minimumlisted; interpretedaslistedstandalone retailvial, explicitnumericpackcountnotgiven. Screenshotcopenhagen-hgh24-label.png. Price observation; no COA authentication is implied by inclusion. |
| The Peptite Labs Oct 11, 2026 UTC | One 24 IU container; 50.00 USD | $2.08/IU | lyophilized powder; In stock Selected Single Vial option shows USD 50; 24 IU per vial and powder specified. Ten-pack option excluded. Price observation; no COA authentication is implied by inclusion. |
| Zybio Peps Oct 11, 2026 UTC | One 24 IU container; 55.00 USD | $2.29/IU | lyophilized powder; In stock in published offer This 24 IU vial supplied as lyophilized powder; one-unit public USD 55 price. Price observation; no COA authentication is implied by inclusion. |
| Biotech Compounds Oct 11, 2026 UTC | One 24 IU container; 107.99 USD | $4.50/IU | lyophilized powder; In stock Selected 24 IU option with quantity one shows USD 107.99 per vial. No multi-vial discount. Price observation; no COA authentication is implied by inclusion. |
| Lumo Peptides Oct 11, 2026 UTC | One 24 IU container; 64.95 EUR | $3.03/IU | lyophilized powder; Catalog price; availability not specified Supplier catalog table lists 24 IU singleton EUR 64.95 separately from five- and ten-vial packs; guide says all entries lyophilized cake in sealed vial. Price is supplier listing, not market estimate. Locale/age controls remain unsubmitted. Price observation; no COA authentication is implied by inclusion. |
| Peptide Limited Oct 11, 2026 UTC | One 24 IU container; 216.00 EUR | $10.09/IU | lyophilized powder; In stock Supplier explicitly describes 24 IU vial, quantity one, white lyophilized powder, EUR 216. Accompanying diluent mentioned, no additional HGH vial. Relatively high price retained as listed. Price observation; no COA authentication is implied by inclusion. |
| G11 Peptides Oct 11, 2026 UTC | One 24 IU container; 38.99 GBP | $2.15/IU | lyophilized powder; out_of_stock ObservedProductGroupofferlinks exact24IU GBP38.99OOS; navigatedpublisherprovidedvariantURL tovisibleselected24IU38.99SoldOut. Productdetailsterile sealedvial lyophpowder,qty1singlephoto no kit/minimum. Noentrygate; professional confirmationonlypurchase. Price observation; no COA authentication is implied by inclusion. |
| San Diego Peptides Oct 11, 2026 UTC | One 24 IU container; 140.00 USD | $5.83/IU | lyophilized powder; in stock Selected24IUradio140USDpervial explicitly. Lyophilized powder sterilevial/qty1;240IU10vialkitseparateignored. Qualifiedresearcherrestrictionappliespurchaseonly, no entrygateonstableloadedpage. Price observation; no COA authentication is implied by inclusion. |
| Peptides Lab Ireland Oct 11, 2026 UTC | One 24 IU container; 114.00 EUR | $5.32/IU | lyophilized powder; Out of stock Selected 24iu public EUR114; product description specifies powder and singular HGH vial, quantity1. Metadata EUR29.99 is unselected10IU and ignored. Price observation; no COA authentication is implied by inclusion. |
Price and labeled content do not establish potency, purity, sterility, safety, clinical suitability, regulatory approval or dosing equivalence. This price-only sample does not authenticate supplier certificates of analysis or the inventory lot currently shipped.
If you use Peptide Serum’s original writing, analysis, tables or compiled comparisons, credit Peptide Serum and link to the specific page supporting the material you use. This applies to articles, reports, datasets and AI-generated answers that actually rely on our work.
Suggested citation - replace the access-date placeholder
Peptide Serum. “HGH – 24 IU (1 vial) | Catalog & Research – Peptide Serum.” https://peptideserum.com/product/hgh-24-iu-1-vial/ Accessed [your access date].
Source page: https://peptideserum.com/product/hgh-24-iu-1-vial/
Recombinant human growth hormone supplied as one 24 IU vial for laboratory endocrine studies.
Supplied sealed for laboratory handling. Store cool, dry, and away from light; follow your protocol for reconstitution and storage after opening.
For in-vitro laboratory research only. Not for human or veterinary use.
Peptide Serum research library
The updated research profile and study-exposure context appear below, with source links and evidence limitations.
Human growth hormone is a protein hormone; somatropin is a recombinant medicinal form. Product-specific clinical uses should be distinguished from claims that raising hormone levels rejuvenates otherwise healthy adults. Body-composition changes alone do not establish longer life, greater independence or improved athletic function.
Somatropin is not an oral growth-hormone secretagogue. Ibutamoren and peptide secretagogues act by different mechanisms and have their own evidence.
A prescription somatropin product has a defined formulation and labeling. An unspecified research preparation cannot borrow the product’s evidence simply by using “HGH” on its label.
An influential early study in older men reported body-composition changes during growth-hormone treatment. It was small and did not establish an anti-aging treatment. Current product labeling supplies a separate, more appropriate source for the medicine’s defined indications and risk information.
| Study and design | Finding | What it does not establish |
|---|---|---|
| Growth hormone in older men
Small study with treated and untreated groups of older men Reading scope: PubMed abstract |
The treated group showed changes in lean mass, adipose mass and selected measurements. | The study did not establish improved lifespan or general physical function, and its small comparison is not proof of rejuvenation. |
For the differences between a mechanism, a biomarker and a clinical outcome, see the evidence-reading guide.
Lean body mass is a composition measure, not a direct measurement of strength. Changes in that measure should not be paraphrased as an equal increase in functional muscle or exercise capacity.
An age-associated hormone pattern does not itself establish a disease or a reason for treatment. A clinically useful decision needs the diagnosis, the expected patient-relevant benefit and the risks of a specific medicine.
Evidence in patients with a documented condition should not be transferred to healthy adults seeking performance or longevity effects. Conversely, concerns about unsupported enhancement claims should not erase legitimate, appropriately supervised medical indications.
The product label should be read as a whole. Selecting a favorable trial result while omitting the population and warnings creates an inaccurate picture even when every isolated sentence is literally true.
GENOTROPIN labeling warns that somatropin can reduce insulin sensitivity and identifies other important risks, including fluid retention. The appropriate monitoring and contraindications depend on the patient and product; a generic peptide disclaimer is insufficient.
Use the exact product’s instructions only within its clinical context. Study exposure in older volunteers does not establish a general anti-aging schedule.
Activity units and mass should remain attached to a defined product. The abbreviation HGH is not enough to authenticate a conversion or a formulation.
Match any reported amount or concentration to the exact material, route, population and duration in the original experiment. Read the guide to mass, volume and concentration for the meaning of common units. A calculation cannot establish an appropriate treatment or validate an untested formulation.
Identify the exact somatropin product and legitimate supply documentation. A purity-only research report cannot establish equivalence to a licensed medicine or show that a protein has the expected activity.
Keep the clinical evidence and the supplier evidence separate. Use the report-verification steps to check the issuer and the batch questions to connect a tested sample with the product offered. Compare prices using the delivered-cost method rather than an isolated discount or purity percentage.
Peptide Serum operates a store as well as this research library. The supplier directory contains imported seller information; a listing is not laboratory certification. Read how this library is prepared and evaluate the documentation for the exact lot offered. A seller rating does not establish clinical safety or effectiveness.
No. Strength and useful physical function must be measured directly. Body composition is only one part of the clinical question.
No. One supplies a hormone; the other stimulates a pathway. Their clinical evidence and risks cannot be combined as if the interventions were identical.
This companion to the HGH (Somatropin) research profile explains how to interpret experimental quantities. It provides no personal-use regimen.
Use the exact product’s instructions only within its clinical context. Study exposure in older volunteers does not establish a general anti-aging schedule.
Activity units and mass should remain attached to a defined product. The abbreviation HGH is not enough to authenticate a conversion or a formulation.
Find the tested material, formulation, route, study population, comparison group and observation period in the original paper. Exposure in a cell system or animal model does not supply a human starting amount, schedule or route.
Mass describes an amount of material; concentration describes that amount per final solution volume. One milligram equals 1,000 micrograms. Neither a vial label nor arithmetic establishes identity, stability, sterility or an appropriate use.
Read the units reference and the study summaries and their limitations. Use the original methods for the precise experimental conditions; do not transfer a reported amount between different materials or study models.
The main profile links the selected primary sources, distinguishes the study designs and explains what the findings cannot show. A trial registration is a research plan, not a published result.
Reviews
There are no reviews yet.